Sunzen Biotech started off specialising in animal health and in the past 25 years, it dabbled in CPO trading, traditional complementary medicine, human supplements and its latest venture - money lending. How does this Bursa Malaysia-listed firm find its niche or does it even need to. Executive director Ching Chee Pun talks about the challenges of navigating these businesses.

PolicyStreet's $26M Series C, Profitability, & Next Phase
21:45

AI Saved Malaysia’s Economy, But For How Long?
23:00

GTA Holdings: A Defence MRO Goes Public
22:51